🇺🇸 Arformoterol and Tiotropium in United States

FDA authorised Arformoterol and Tiotropium on 30 January 2004

Marketing authorisations

FDA — authorised 30 January 2004

  • Application: NDA021395
  • Marketing authorisation holder: BOEHRINGER INGELHEIM
  • Local brand name: SPIRIVA
  • Indication: POWDER — INHALATION
  • Status: approved

Read official source →

FDA

  • Status: approved

Arformoterol and Tiotropium in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Arformoterol and Tiotropium approved in United States?

Yes. FDA authorised it on 30 January 2004; FDA has authorised it.

Who is the marketing authorisation holder for Arformoterol and Tiotropium in United States?

BOEHRINGER INGELHEIM holds the US marketing authorisation.